Both Raloxifene And Tamoxifen Is Protect Against Breast Cancer – Part 3 of 3
Invasive cancer is disease that has disseminating outside of the ducts and is most life-threatening. Wickerham concluded that raloxifene would be a “reasonable choice for a substantial number of women at increased risk for breast cancer. There are lots of women already taking raloxifene to supporter maintain bone density and reduce the risk of vertebral fractures. From my perspective, these women would be candidates to consider raloxifene because now you’ve got a two-for-one benefit”.
Women at risk for blood clots should be wary of taking either drug. If a skirt is at high risk for uterine cancer – she has a strong family history, is obese or has diabetes, for instance – she might consider raloxifene first. “I do believe that I’m preventing this ailment from getting me,” said Marty Smith, 55, of Grand Rapids, Mich, who has taken both tamoxifen and raloxifene and was involved with the STAR trial. Smith has a strong family retailing of breast cancer and, although she is not taking either drug right now, is planning to talk to her doctor about resuming raloxifene in the wake of these results.